Berenberg Bank restated their buy rating on shares of Abcam (LON:ABC) in a research report report published on Friday. The brokerage currently has a GBX 1,240 ($16.58) target price on the stock.

A number of other brokerages also recently commented on ABC. Peel Hunt reissued a hold rating and issued a GBX 750 ($10.03) price objective on shares of Abcam in a research report on Monday, September 11th. Panmure Gordon reissued a sell rating on shares of Abcam in a research report on Monday, September 11th. Numis Securities increased their price objective on shares of Abcam from GBX 1,116 ($14.92) to GBX 1,200 ($16.04) and gave the company an add rating in a research report on Tuesday, September 12th. Finally, JPMorgan Chase & Co. reissued a neutral rating and issued a GBX 864 ($11.55) price objective on shares of Abcam in a research report on Tuesday, September 12th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. Abcam has a consensus rating of Hold and an average price target of GBX 996 ($13.32).

Shares of Abcam (LON:ABC) opened at GBX 1,089 ($14.56) on Friday. Abcam has a 52 week low of GBX 9.73 ($0.13) and a 52 week high of GBX 1,113 ($14.88). The firm has a market cap of $2,230.00 and a P/E ratio of 5,185.71.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/abcams-abc-buy-rating-reaffirmed-at-berenberg-bank/1797293.html.

Abcam Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam (LON:ABC)

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with Analyst Ratings Network's FREE daily email newsletter.